More importantly, exciting novel findings from this study present new evidence linking the deficiencies of DNA damage repair genes (POLQ/FANCD2) with the activation of anti-tumor immunity through the cGAS-STING-STAT1 signaling pathway. The gene discussed is STAT1; the disease is neoplasm.